Anti-malarial drug breakthrough


    Max Planck Institute Develop Breakthrough Synthesis Method for key anti-malarial drug Artemisinin, using Vapourtec flow system.


    January 17th 2012

    Scientists at the laboratory of Peter Seeberger in the Max Planck Institute in Potsdam, Germany, have developed a new synthesis route that makes it possible for the best anti-malarial drug, Artemisinin , to be manufactered in sufficient quantity, and at a low enough price, for world demand to be affordably met.

    Using a Vapourtec R Series system and a photo reactor they developed at the institute, researchers were able to synthesise Artemisinin from more easily obtainable Artemisinic acid.


    More information – Vapourtec

    Find out more

    Find out more about the Vapourtec R Series flow chemistry platform used for this work.

    {}Download Broachure

    Download Vapourtec R Series Brochure

    Register for newsletter

    FREE bimonthly email newsletter highlighting latest developments and publications in flow chemistry (such as this) when they happen.


    More information – The research work


    See the publication in the Angewante Chemie Journal where the breakthrough was first described.

    Max Planck Institute Press release

    Official press release put out by the Max Planck Institute, explaining the background to this work and how it fits in with the overall global effort to combat malaria.

    Feature on German TV news

    TV news report, which shows the equipment in use (this is in German)

    Get in touch

    For more information on flow chemistry systems and services please use the contact methods below.

    Call us on +44 (0)1284 728659 or Email us